Efficacy and Safety of Sildenafil Added to Treprostinil in Pulmonary Hypertension
- 1 November 2005
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 96 (9), 1334-1336
- https://doi.org/10.1016/j.amjcard.2005.06.083
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Treatment of Pulmonary Arterial HypertensionNew England Journal of Medicine, 2004
- Clinical efficacy of sildenafil in primary pulmonary hypertensionJournal of the American College of Cardiology, 2004
- Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertensionJournal of the American College of Cardiology, 2003
- Survival in Primary Pulmonary HypertensionCirculation, 2002
- Oral Sildenafil Is an Effective and Specific Pulmonary Vasodilator in Patients With Pulmonary Arterial HypertensionCirculation, 2002
- Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Role of Nitric Oxide in the Local Regulation of Pulmonary Vascular Resistance in HumansCirculation, 1996
- Changes in dyspnea-fatigue ratings as indicators of quality of life in the treatment of congestive heart failureThe American Journal of Cardiology, 1989
- Prostacyclin: Homeostatic Regulator or Biological Curiosity?Clinical Science, 1981
- Treadmill exercise in assessment of the functional capacity of patients with cardiac diseaseThe American Journal of Cardiology, 1972